
Bruce G. Raphael, MD, discusses the utility of venetoclax and obinutuzumab in chronic lymphocytic leukemia.

Your AI-Trained Oncology Knowledge Connection!


Bruce G. Raphael, MD, discusses the utility of venetoclax and obinutuzumab in chronic lymphocytic leukemia.

Bruce G. Raphael, MD, discusses the risk of tumor lysis syndrome in chronic lymphocytic leukemia.

Bruce G. Raphael, MD, a clinical professor in the Department of Medicine at NYU Langone Health, discusses the phase II CLARITY trial in chronic lymphocytic leukemia (CLL).

Bruce G. Raphael, MD, discusses the treatment landscape of chronic lymphocytic leukemia.

Published: March 3rd 2020 | Updated:

Published: March 10th 2020 | Updated:

Published: April 4th 2020 | Updated:

Published: May 8th 2020 | Updated: